FEDERAL HEALTH POLICY STRATEGIES

Lobbying for MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL · Opioid treatment program facilities and practices

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $50,000.00 income · posted Apr 18, 2025

Bills named in this filing 2

S 1359
STOP CCP Act of 2025
HR 644
Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025

Lobbying activity 1

Health Issues

Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644) Access to medication-assisted treatment and Medicaid reform

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.